News

Johnson & Johnson MedTech* has announced that DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, is introducing a new dual-use robotics and standalone navigation platform, developed in collaboration with eCential Robotics. This system, named the VELYS™ Active Robotic-Assisted System (VELYS™ SPINE), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is designed for planning and executing spinal fusion procedures in the cervical, thoracolumbar, and sacroiliac spine.

This innovative spine technology is designed to assist surgeons in addressing their most complex challenges. The VELYS™ SPINE system offers dual-use functionality, featuring both standalone navigation and an active robotics platform that allows for surgeon flexibility in their approach and planning. The active robotics component provides surgical guidance that can be customized to the surgeon’s preferences. The unique features and capabilities of this technology are poised to set a new benchmark in spine surgery care.

“We are shaping the next frontier of orthopaedic innovation with a relentless focus on digital advancements and excellence in the field of surgical robotics and navigation. Our dedication extends to enhancing patient care through significant strides in spine surgery,” said Aldo Denti, Company Group Chair, DePuy Synthes. “This is a major step in growing our VELYS™ Portfolio and in our commitment to supporting spine surgeons and their patients with advanced tools.”

The VELYS™ SPINE system is tailored to meet the complex needs of spine surgeons, offering a customizable experience with workflows specific to different pathologies. This is enhanced by features such as VELYS™ ADAPTIVE TRACKING TECHNOLOGY and VELYS™ Trajectory Assistance. The system will be used in conjunction with DePuy Synthes’ core Spine portfolio, including the TriALTIS™ Spine System, Navigation Enabled Instruments, SYMPHONY™ Occipito-Cervico-Thoracic (OCT) System, VIPER PRIME™ System, and EXPEDIUM VERSE® Systems.

“Today’s landscape of enabling technologies features first-generation robotics systems that may face challenges in adapting to individual surgeon needs,” said Russell Powers, Worldwide President, Spine, DePuy Synthes. “We recognize the urgent need for innovative solutions that offer new ways to engage with enabling technologies, returning control to surgeon’s hands. We believe that the unique features and capabilities of active robotics technology will set a new standard in surgical care for spine patients everywhere.”

The VELYS™ SPINE system will be showcased across the U.S. in the MedTech Innovation Experience mobile lab, alongside other technologies and products currently available in DePuy Synthes’ comprehensive Spine portfolio. This MedTech Innovation Experience provides hands-on learning opportunities for surgeons, fellows, residents, and other healthcare professionals. The system is expected to be commercially available in the first half of 2025. More information about the VELYS™ SPINE system can be found at: ActiveRoboticAssistance.com

© Johnson & Johnson